UCB's Cimzia touted as potential top-seller

Belgium's UCB is riding high today after it won the FDA nod for a new indication for Cimzia as a rheumatoid arthritis remedy. Company officials and some analysts said the drug could be an up-and-coming blockbuster. Report

Suggested Articles

Pharma

CSL sues former exec for trade secrets theft

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

by Eric Sagonowsky
Manufacturing

New CDMO, backed by private equity player, to make biologics

Private equity player Ampersand Capital Partners is backing another CDMO, this one targeted at sterile injectables.

by Eric Palmer
ReputationSign
Marketing

J&J tumbles in annual listing of best global brands

How much are lawsuits hurting J&J's brand? The New Jersey drugmaker has lost half a billion dollars in brand value over the past year, a report says.

by Beth Snyder Bulik